Safety and Preliminary Efficacy of TISA-818 Injection in Patients With Acute Respiratory Distress Syndrome

NCT07319351 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Respiratory Distress Syndrome (ARDS)

Interventions

DRUG: TISA-818-Inj
DRUG: TISA-818-Inj
DRUG: Placebo

Sponsor

EnliTISA (Shanghai) Pharmaceutical Co., Ltd.